Saisei Ventures
@saiseiventures.bsky.social
Accelerating returns by connecting Japanese innovations to global expertise
日本発イノベーションを世界の専門知識で大きく成長させる
www.saiseiventures.com
日本発イノベーションを世界の専門知識で大きく成長させる
www.saiseiventures.com
@biosurgerysven.bsky.social and Sonny Dhawan had an exciting time at ARM's 2025 Cell & Gene Meeting on the Mesa!
Sven spoke with IBTV to share some highlights from the meeting, and reflected on ARM’s continued dedication to patient advocacy.
www.youtube.com/watch?v=K12G...
#CGMesa25
Sven spoke with IBTV to share some highlights from the meeting, and reflected on ARM’s continued dedication to patient advocacy.
www.youtube.com/watch?v=K12G...
#CGMesa25
Saisei Ventures' Sven Kili talks to IBTV at ARM / Cell & Gene's Meeting on the Mesa 2025
YouTube video by IBTV
www.youtube.com
October 21, 2025 at 2:35 PM
@biosurgerysven.bsky.social and Sonny Dhawan had an exciting time at ARM's 2025 Cell & Gene Meeting on the Mesa!
Sven spoke with IBTV to share some highlights from the meeting, and reflected on ARM’s continued dedication to patient advocacy.
www.youtube.com/watch?v=K12G...
#CGMesa25
Sven spoke with IBTV to share some highlights from the meeting, and reflected on ARM’s continued dedication to patient advocacy.
www.youtube.com/watch?v=K12G...
#CGMesa25
Kenai Therapeutics is on a mission to cure neurological conditions like #Parkinsons using #celltherapies. Nick Manusos, CEO of Kenai, joined The Bio Hub to share his path to Kenai, and the lessons he learned along the way. #SaiseiPortCo @kenaitx.bsky.social
Listen here: bit.ly/42aLMSY
Listen here: bit.ly/42aLMSY
The BioHub - The Avetix Podcast - S2 Ep71 - Nick Manusos - CEO of Kenai Therapeutics
Welcome back to another episode of The BioHub, we were delighted to welcome on Nick Manusos, the CEO of Kenai Therapeutics, a pioneering biotech company developing neuron replacement therapies for neurological disorders. Nick’s journey spans decades of innovation and leadership—from senior roles at global pharma giants like Baxter, Takeda, and Abbott, to founding and leading cutting-edge startups like Iota Biosciences and Opsis Therapeutics. Under his guidance, Kenai Therapeutics has secured groundbreaking funding and is advancing life-changing therapies for patients with Parkinson’s disease. He holds an MBA from Northwestern University’s Kellogg School of Management and a BBA from the University of Wisconsin, bringing a rare combination of business acumen and scientific vision to the table. Nick joins us today to share his insights on pioneering stem cell therapies, building biotech startups from the ground up, and what it takes to turn cutting-edge science into real-world solutions.
bit.ly
September 25, 2025 at 2:58 PM
Kenai Therapeutics is on a mission to cure neurological conditions like #Parkinsons using #celltherapies. Nick Manusos, CEO of Kenai, joined The Bio Hub to share his path to Kenai, and the lessons he learned along the way. #SaiseiPortCo @kenaitx.bsky.social
Listen here: bit.ly/42aLMSY
Listen here: bit.ly/42aLMSY
#AdvancedTherapiesEurope challenged us to think differently about how to scale advanced therapies and bring them to patients faster. @biosurgerysven.bsky.social and Miguel Forte came away feeling energized by the work the community is doing. We can’t wait to be back next year! #ATE25
September 16, 2025 at 7:24 PM
#AdvancedTherapiesEurope challenged us to think differently about how to scale advanced therapies and bring them to patients faster. @biosurgerysven.bsky.social and Miguel Forte came away feeling energized by the work the community is doing. We can’t wait to be back next year! #ATE25
日本の製薬業界において20年以上のリーダーシップ経験を持つ、ジェームズ・フェリシアーノ氏のベンチャーパートナー就任を歓迎します！サイセイでは、ポートフォリオ企業と共に開発戦略の立案を支援します。詳細はこちら：http://bit.ly/4ppZScX
September 15, 2025 at 10:02 PM
日本の製薬業界において20年以上のリーダーシップ経験を持つ、ジェームズ・フェリシアーノ氏のベンチャーパートナー就任を歓迎します！サイセイでは、ポートフォリオ企業と共に開発戦略の立案を支援します。詳細はこちら：http://bit.ly/4ppZScX
We’re excited to welcome James Feliciano as a venture partner! With 20+ years of pharma leadership experience in #Japan, he will help guide development strategies alongside our portfolio companies. Learn more: bit.ly/4ppZScX
September 15, 2025 at 1:01 PM
We’re excited to welcome James Feliciano as a venture partner! With 20+ years of pharma leadership experience in #Japan, he will help guide development strategies alongside our portfolio companies. Learn more: bit.ly/4ppZScX
Congrats to our intern, Siwei Huang, on her research presentation! Siwei is an MSc student at #UCL, and her research involved creating an AI Usage Scale to measure how meaningfully companies are using #AI and #ML in the #drugdevelopment process.
September 12, 2025 at 3:00 PM
Congrats to our intern, Siwei Huang, on her research presentation! Siwei is an MSc student at #UCL, and her research involved creating an AI Usage Scale to measure how meaningfully companies are using #AI and #ML in the #drugdevelopment process.
Managing Partner @jonathanyeh.bsky.social joined fellow #biotech and #VC experts at the #AsiaBioPartneringForum! His session focused on the future of biotech investing in Asia, where panelists provided insights into how companies can successfully navigate regulatory and funding shifts.
September 11, 2025 at 5:33 PM
Managing Partner @jonathanyeh.bsky.social joined fellow #biotech and #VC experts at the #AsiaBioPartneringForum! His session focused on the future of biotech investing in Asia, where panelists provided insights into how companies can successfully navigate regulatory and funding shifts.
Join us in welcoming our Graduate Associates! This inspiring group of Kyushu University students will be working alongside us for the next year to lend their scientific expertise to our investment work, while gaining hands-on experience in the biotech industry. We’re excited to have them on board!
September 8, 2025 at 5:07 PM
Join us in welcoming our Graduate Associates! This inspiring group of Kyushu University students will be working alongside us for the next year to lend their scientific expertise to our investment work, while gaining hands-on experience in the biotech industry. We’re excited to have them on board!
What will it take to unlock the full potential of #GeneEditing?
In the latest issue of Cell & Gene Therapy Insights,
@biosurgerysven.bsky.social examines the gene editing landscape and shares his perspective on how to bring lasting impact to patients.
Read the full issue here: bit.ly/464OE4S
In the latest issue of Cell & Gene Therapy Insights,
@biosurgerysven.bsky.social examines the gene editing landscape and shares his perspective on how to bring lasting impact to patients.
Read the full issue here: bit.ly/464OE4S
September 5, 2025 at 9:06 PM
What will it take to unlock the full potential of #GeneEditing?
In the latest issue of Cell & Gene Therapy Insights,
@biosurgerysven.bsky.social examines the gene editing landscape and shares his perspective on how to bring lasting impact to patients.
Read the full issue here: bit.ly/464OE4S
In the latest issue of Cell & Gene Therapy Insights,
@biosurgerysven.bsky.social examines the gene editing landscape and shares his perspective on how to bring lasting impact to patients.
Read the full issue here: bit.ly/464OE4S
Sven Kili is in Barcelona this week for #AdvancedTherapiesEurope!
He joined biotech industry experts to discuss the fundraising landscape for #CGT startups, bringing a unique perspective as both an investor and clinician.
Thanks to Phacilitate for organizing! #ATE25 @biosurgerysven.bsky.social
He joined biotech industry experts to discuss the fundraising landscape for #CGT startups, bringing a unique perspective as both an investor and clinician.
Thanks to Phacilitate for organizing! #ATE25 @biosurgerysven.bsky.social
September 3, 2025 at 2:59 PM
Sven Kili is in Barcelona this week for #AdvancedTherapiesEurope!
He joined biotech industry experts to discuss the fundraising landscape for #CGT startups, bringing a unique perspective as both an investor and clinician.
Thanks to Phacilitate for organizing! #ATE25 @biosurgerysven.bsky.social
He joined biotech industry experts to discuss the fundraising landscape for #CGT startups, bringing a unique perspective as both an investor and clinician.
Thanks to Phacilitate for organizing! #ATE25 @biosurgerysven.bsky.social
Who really funds global #DrugDevelopment?
Jonathan Yeh, Managing Partner at Saisei, discusses how the future of healthcare innovation depends on contributions from the entire global ecosystem, rather than a single market.
Read more: bit.ly/477CSc7
Jonathan Yeh, Managing Partner at Saisei, discusses how the future of healthcare innovation depends on contributions from the entire global ecosystem, rather than a single market.
Read more: bit.ly/477CSc7
August 21, 2025 at 1:01 PM
Who really funds global #DrugDevelopment?
Jonathan Yeh, Managing Partner at Saisei, discusses how the future of healthcare innovation depends on contributions from the entire global ecosystem, rather than a single market.
Read more: bit.ly/477CSc7
Jonathan Yeh, Managing Partner at Saisei, discusses how the future of healthcare innovation depends on contributions from the entire global ecosystem, rather than a single market.
Read more: bit.ly/477CSc7
We’re thrilled to partner with Japan’s #MHLW on the new Drug Discovery Ecosystem Development Support Project!
This program will connect #biotech startups with world-class experts in order to advance their discoveries and help make an impact for patients worldwide.
Learn more: bit.ly/3Jj0r82
This program will connect #biotech startups with world-class experts in order to advance their discoveries and help make an impact for patients worldwide.
Learn more: bit.ly/3Jj0r82
August 18, 2025 at 12:30 PM
We’re thrilled to partner with Japan’s #MHLW on the new Drug Discovery Ecosystem Development Support Project!
This program will connect #biotech startups with world-class experts in order to advance their discoveries and help make an impact for patients worldwide.
Learn more: bit.ly/3Jj0r82
This program will connect #biotech startups with world-class experts in order to advance their discoveries and help make an impact for patients worldwide.
Learn more: bit.ly/3Jj0r82
At #Expo2025Osaka - a global event dedicated to “Designing Future Society for Our Lives” - #SaiseiPortCo United Immunity’s breakthrough platform was named UCB Pharma’s “Most Innovative Technology with Potential for Disruption.” Congrats to President Masato Kishida & team on this incredible honor!
June 26, 2025 at 1:59 PM
At #Expo2025Osaka - a global event dedicated to “Designing Future Society for Our Lives” - #SaiseiPortCo United Immunity’s breakthrough platform was named UCB Pharma’s “Most Innovative Technology with Potential for Disruption.” Congrats to President Masato Kishida & team on this incredible honor!
Congrats to @biosurgerysven.bsky.social and cofounders Michelle Boxall and Lee Buckler on launching Advanced Therapies Think Tank - #AT3, a new platform for unfiltered discussions on the advancement of cell & gene therapies. Season 1 starts July 3!
Learn more: www.advancedtherapiesthinktank.com
Learn more: www.advancedtherapiesthinktank.com
June 18, 2025 at 3:29 PM
Congrats to @biosurgerysven.bsky.social and cofounders Michelle Boxall and Lee Buckler on launching Advanced Therapies Think Tank - #AT3, a new platform for unfiltered discussions on the advancement of cell & gene therapies. Season 1 starts July 3!
Learn more: www.advancedtherapiesthinktank.com
Learn more: www.advancedtherapiesthinktank.com
The #ASCO2025 Annual Meeting is here! Sonny Dhawan, PhD, is in Chicago and excited to meet with colleagues and partners to discuss the future of #oncology.
Welcome to #ASCO25! The energy is electric as we kick off a week of scientific discovery, breakthroughs, and inspiring connections. Get ready to dive deep into oncology advancements and shape the future of cancer care.
We're thrilled you're here!
We're thrilled you're here!
May 31, 2025 at 7:28 PM
The rise of #entrepreneurship is quietly reshaping Japan’s workforce.
In a new article, Jonathan Yeh, Managing Partner, shares his perspective on how a new generation is breaking from tradition to embrace #startups and #innovation. Read more: bit.ly/4kGenXa
In a new article, Jonathan Yeh, Managing Partner, shares his perspective on how a new generation is breaking from tradition to embrace #startups and #innovation. Read more: bit.ly/4kGenXa
May 28, 2025 at 2:53 PM
The rise of #entrepreneurship is quietly reshaping Japan’s workforce.
In a new article, Jonathan Yeh, Managing Partner, shares his perspective on how a new generation is breaking from tradition to embrace #startups and #innovation. Read more: bit.ly/4kGenXa
In a new article, Jonathan Yeh, Managing Partner, shares his perspective on how a new generation is breaking from tradition to embrace #startups and #innovation. Read more: bit.ly/4kGenXa
Our team is in New Orleans for #ASGCT2025! Excited to connect with innovators and explore the latest in cell & gene therapy. Researchers-let’s chat! Message us here or find Yusuke Wada, Ph.D. or Sonny Dhawan, Ph.D. between sessions. Hope to see you there! @asgct.bsky.social
May 13, 2025 at 3:13 PM
Our team is in New Orleans for #ASGCT2025! Excited to connect with innovators and explore the latest in cell & gene therapy. Researchers-let’s chat! Message us here or find Yusuke Wada, Ph.D. or Sonny Dhawan, Ph.D. between sessions. Hope to see you there! @asgct.bsky.social
Saisei が行っている次世代リーダー育成プログラム "Executive Fellows Program" のメンター、Audrey GreenbergさんとMiguel Forteさんが、The Medicine Maker 2025 #PowerList に選出されました！
グローバルリーダーとしてのご実績、おめでとうございます！
受賞者一覧はこちら bit.ly/4m3AGHK
グローバルリーダーとしてのご実績、おめでとうございます！
受賞者一覧はこちら bit.ly/4m3AGHK
May 5, 2025 at 12:23 AM
Saisei が行っている次世代リーダー育成プログラム "Executive Fellows Program" のメンター、Audrey GreenbergさんとMiguel Forteさんが、The Medicine Maker 2025 #PowerList に選出されました！
グローバルリーダーとしてのご実績、おめでとうございます！
受賞者一覧はこちら bit.ly/4m3AGHK
グローバルリーダーとしてのご実績、おめでとうございます！
受賞者一覧はこちら bit.ly/4m3AGHK
Congratulations to Audrey Greenberg and Miguel Forte, our Executive Fellow Mentors, on being named to The Medicine Maker 2025 #PowerList! A well-deserved honor for two inspiring leaders. See the full list here: bit.ly/4m3AGHK
May 5, 2025 at 12:23 AM
Congratulations to Audrey Greenberg and Miguel Forte, our Executive Fellow Mentors, on being named to The Medicine Maker 2025 #PowerList! A well-deserved honor for two inspiring leaders. See the full list here: bit.ly/4m3AGHK
Congratulations to the #Craif team on their Series C financing! Craif is a molecular diagnostic company focused on #EarlyCancerDetection by analyzing a patient's microRNA.
Learn more: craif.com/en/20250428-...
#SaiseiPortCo
Learn more: craif.com/en/20250428-...
#SaiseiPortCo
April 28, 2025 at 8:59 PM
Congratulations to the #Craif team on their Series C financing! Craif is a molecular diagnostic company focused on #EarlyCancerDetection by analyzing a patient's microRNA.
Learn more: craif.com/en/20250428-...
#SaiseiPortCo
Learn more: craif.com/en/20250428-...
#SaiseiPortCo
Saisei Ventures は、今年11月開催の #Science2StartupJapanに協賛します！S2S Japanは、トップ研究者とグローバルな投資家、製薬企業を結びつけ、#バイオテック #イノベーションを推進し、日本のライフサイエンスエコシステムを強化することを目的としたイベントです。応募は5/9まで！詳細・応募はこちら：https://s2s-japan.com/en/ #S2SJapan
April 25, 2025 at 5:49 PM
Saisei Ventures は、今年11月開催の #Science2StartupJapanに協賛します！S2S Japanは、トップ研究者とグローバルな投資家、製薬企業を結びつけ、#バイオテック #イノベーションを推進し、日本のライフサイエンスエコシステムを強化することを目的としたイベントです。応募は5/9まで！詳細・応募はこちら：https://s2s-japan.com/en/ #S2SJapan
We're a proud sponsor of #Science2StartupJapan! S2S Japan aims to enhance Japan's life sciences ecosystem by connecting top researchers with global investors, pharmaceutical companies to advance #biotech #innovation. Apply by May 9 to join the class of 2025: s2s-japan.com/en/ #S2SJapan
April 25, 2025 at 5:48 PM
We're a proud sponsor of #Science2StartupJapan! S2S Japan aims to enhance Japan's life sciences ecosystem by connecting top researchers with global investors, pharmaceutical companies to advance #biotech #innovation. Apply by May 9 to join the class of 2025: s2s-japan.com/en/ #S2SJapan
日本の次世代バイオテクノロジーリーダーを指導する、「エグゼクティブ・フェロー・プログラム」を開始します！第1回のメンターを務めていただくJeff Abbey、Usman "Oz" Azam、Miguel Forte、Audrey Greenberg に感謝を表します。
詳細はこちら：
bit.ly/3G9hOXd
詳細はこちら：
bit.ly/3G9hOXd
Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan’s Biotech Leadership Pipeline
Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced the launch of its...
bit.ly
April 14, 2025 at 12:08 PM
日本の次世代バイオテクノロジーリーダーを指導する、「エグゼクティブ・フェロー・プログラム」を開始します！第1回のメンターを務めていただくJeff Abbey、Usman "Oz" Azam、Miguel Forte、Audrey Greenberg に感謝を表します。
詳細はこちら：
bit.ly/3G9hOXd
詳細はこちら：
bit.ly/3G9hOXd
We’re excited to launch the Executive Fellows Program to mentor the next generation of biotech leaders in Japan. Welcome to our inaugural mentors: Jeff Abbey, Oz Azam, Miguel Forte & Audrey Greenberg! Learn more: bit.ly/3G9hOXd
Saisei Ventures Launches Executive Fellows Program Aiming to Enhance Japan’s Biotech Leadership Pipeline
Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced the launch of its...
bit.ly
April 14, 2025 at 12:05 PM
We’re excited to launch the Executive Fellows Program to mentor the next generation of biotech leaders in Japan. Welcome to our inaugural mentors: Jeff Abbey, Oz Azam, Miguel Forte & Audrey Greenberg! Learn more: bit.ly/3G9hOXd
We're in Rome for the Cell & Gene Meeting on the Mediterranean! Join @biosurgerysven.bsky.social as he moderates a panel discussion on the dynamic ATMP investment landscape.
Date: Wednesday, April 16
Time: 10:45 AM
Location: Salone dei Cavalieri, Section 3&4
Full agenda: bit.ly/42kLqs1
#CGMed25
Date: Wednesday, April 16
Time: 10:45 AM
Location: Salone dei Cavalieri, Section 3&4
Full agenda: bit.ly/42kLqs1
#CGMed25
April 10, 2025 at 3:51 PM
We're in Rome for the Cell & Gene Meeting on the Mediterranean! Join @biosurgerysven.bsky.social as he moderates a panel discussion on the dynamic ATMP investment landscape.
Date: Wednesday, April 16
Time: 10:45 AM
Location: Salone dei Cavalieri, Section 3&4
Full agenda: bit.ly/42kLqs1
#CGMed25
Date: Wednesday, April 16
Time: 10:45 AM
Location: Salone dei Cavalieri, Section 3&4
Full agenda: bit.ly/42kLqs1
#CGMed25